Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells

Benzer Materyaller

• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  Yazar:: Chen, W, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  Yazar:: Sandham, D, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
  Yazar:: Hardman, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
  Yazar:: Xue, L, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
  Yazar:: Veit J. Erpenbeck, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-12-01)